nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW
6,302
edits
Changes
Jump to navigation
Jump to search
Create page
'''Medistem Inc.''' is an [[United States of America|American]] public company founded in October 2005 traded on the OTC Bulletin Board Market. Its stated mission is "to discover, develop and commercialize technologies related to [[adult]] [[stem cell]] extraction and manipulation for use in treating inflammatory and degenerative [[disease]]s".
As of August 2008, the company has a variety of products in various stages of development which are covered by [[patent]] applications. Although Medistem utilises stem cells they are only derived from non-controversial, adult stem cells.
Medistem's patent applications include novel uses of stem cells, methods of stem cell expansion, methods of [[cancer]] treatment and new approaches to conditions such as [[autism]] and neurodegenerative illnesses.
==External links==
[http://www.medisteminc.com/ Medistem home page]
As of August 2008, the company has a variety of products in various stages of development which are covered by [[patent]] applications. Although Medistem utilises stem cells they are only derived from non-controversial, adult stem cells.
Medistem's patent applications include novel uses of stem cells, methods of stem cell expansion, methods of [[cancer]] treatment and new approaches to conditions such as [[autism]] and neurodegenerative illnesses.
==External links==
[http://www.medisteminc.com/ Medistem home page]